Opioids for chronic breathlessness: no evidence of clinically relevant adverse effects

Physicians have been reluctant to prescribe opioids for patients with chronic breathlessness due to concerns about adverse respiratory effects. However, a study published in the November issue of the European Respiratory Journal has found no significant or clinically relevant evidence of respiratory adverse effects caused by opioids prescribed for chronic breathlessness. Find out more here or visit erj.ersjournals.com to read other articles in the latest issue.